DAVID M MOTT Insider Trading $SYBX SYNLOGIC, INC.
Get free email notifications about insider trading for DAVID M MOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and Director in NOVAVAX INC ($NVAX) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and Director in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and Director in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and Director in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Epizyme, Inc. ($EPZM) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in IMARA Inc. ($IMRA) and 10% Owner in Elastic N.V. ($ESTC) and Director in Nightstar Therapeutics plc ($NITE) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM).
DAVID M MOTT in SYNLOGIC, INC.
Trading Symbol: SYBXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 4,228,940 shares
Current Value: $9,303,668
Latest Transaction: Jan 26 2018
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID M MOTT in SYNLOGIC, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ADAP, APPN, ABIO, ARDX, AVEO, CRCM, CASC, CERC, ESTC, EPZM, GNCA, IMRA, ILIU, MEDI, MRSN, MIRM, MULE, NITE, NVAX, RARX, RGLS, RYTM, ROKA, SURF, SYBX, TSRO, TCON, TRVI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2018 | MIRN | SYNLOGIC, INC. | MOTT DAVID M | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
Aug 30 2017 | MIRN | SYNLOGIC, INC. | MOTT DAVID M | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 583,559 | 0 | 0 | |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 1,241,650 | 0 | 0 | |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | MOTT DAVID M | 10% Owner | Buy | P | 7.00 | 857,142 | 5,999,994 | 2,971,517 | 2.1 M to 3 M (+40.54 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | MOTT DAVID M | 10% Owner | Buy | J | 0.00 | 31,650 | 0 | 2,114,375 | 2.1 M to 2.1 M (+1.52 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 583,559 | 0 | 2,082,725 | 1.5 M to 2.1 M (+38.93 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | MOTT DAVID M | 10% Owner | Buy | J | 0.00 | 257,516 | 0 | 1,499,166 | 1.2 M to 1.5 M (+20.74 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 1,241,650 | 0 | 1,241,650 | 0 to 1.2 M |
Page: 1